SCHEMBL21189158

SCHEMBL21189158

Cn1c(S)nc2cnccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.56
NPC1 O15118 2/20 0.49
TP53 P04637 2/20 0.49
MAPT P10636 2/20 0.49
RAB9A P51151 2/20 0.49
CASP1 P29466 1/20 0.49
RPS6KA5 O75582 8/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
POLB P06746 1/20 0.48
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 1/20 0.47
LMNA P02545 1/20 0.47
HPGD P15428 1/20 0.47
HSD17B10 Q99714 1/20 0.47
USP2 O75604 1/20 0.40
HTT P42858 1/20 0.40
NCOA1 Q15788 1/20 0.40
NCOA3 Q9Y6Q9 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2053477 0.78 ATM (0.62) ATMNPC1TP53MAPTRAB9A
SCHEMBL16083675 0.77 SMN1; SMN2 (0.60) ATMNPC1TP53MAPTRAB9A
SCHEMBL19233638 0.77 ATM (0.56) ATMNPC1TP53MAPTRAB9A
SCHEMBL31298627 0.77 SMN1; SMN2 (0.60) ATMNPC1TP53MAPTRAB9A
SCHEMBL25080570 0.76 ATM (0.54) ATMNPC1TP53MAPTRAB9A
SCHEMBL21041642 0.74 ATM (0.53) ATMNPC1TP53MAPTRAB9A
SCHEMBL21540392 0.74 ATM (0.53) ATMNPC1TP53MAPTRAB9A
SCHEMBL11946716 0.74 ATM (0.53) ATMNPC1TP53MAPTRAB9A
SCHEMBL11916064 0.74 ATM (0.53) ATMNPC1TP53MAPTRAB9A
SCHEMBL18306495 0.74 ATM (0.49) ATMNPC1TP53MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10399978-B2 Imidazopyridine thioglycolic acid derivatives as potent inhibitors of human urate transporter 1 SHANDONG UNIVERSITY (CN) 2019-09-03 US disclosed
US-20190225606-A1 Novel Imidazopyridine Thioglycolic Acid Derivatives as Potent Inhibitors of Human Urate Transporter 1 SHANDONG UNIVERSITY (CN) 2019-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190225606-A1 Novel Imidazopyridine Thioglycolic Acid Derivatives as Potent Inhibitors of Human Urate Transporter 1 SLC29A1, SLC28A1, SLC5A1 ATM 4793/4885NPC1 194/4885TP53 3791/4885
US-10399978-B2 Imidazopyridine thioglycolic acid derivatives as potent inhibitors of human urate transporter 1 SLC29A1, SLC28A1, SLC5A1 ATM 4747/4885NPC1 244/4885TP53 3319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.